Literature DB >> 15782213

Different delivery methods-different expression profiles.

Yuriy Fedorov, Alan King, Emily Anderson, Jon Karpilow, Diane Ilsley, William Marshall, Anastasia Khvorova.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15782213     DOI： 10.1038/nmeth0405-241

Source DB:  PubMed          Journal:  Nat Methods        ISSN： 1548-7091            Impact factor:   28.547


× No keyword cloud information.
  24 in total

Review 1.  Delivery of siRNA therapeutics: barriers and carriers.

Authors:  Jie Wang; Ze Lu; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2010-06-11       Impact factor: 4.009

Review 2.  Silence of the transcripts: RNA interference in medicine.

Authors:  Sailen Barik
Journal:  J Mol Med (Berl)       Date:  2005-07-19       Impact factor: 4.599

Review 3.  Nonviral delivery of synthetic siRNAs in vivo.

Authors:  Saghir Akhtar; Ibrahim F Benter
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 4.  Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?

Authors:  Dirk Grimm; Mark A Kay
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 5.  RNAi therapeutics: principles, prospects and challenges.

Authors:  Lars Aagaard; John J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2007-03-16       Impact factor: 15.470

6.  RNA interference in human foreskin fibroblasts within the three-dimensional collagen matrix.

Authors:  Mark A Carlson; Amy K Prall; Jeremiah J Gums
Journal:  Mol Cell Biochem       Date:  2007-07-27       Impact factor: 3.396

7.  Transfection of cells using flow-through electroporation based on constant voltage.

Authors:  Tao Geng; Yihong Zhan; Jun Wang; Chang Lu
Journal:  Nat Protoc       Date:  2011-07-21       Impact factor: 13.491

8.  REM sleep changes in rats induced by siRNA-mediated orexin knockdown.

Authors:  Lichao Chen; Mahesh M Thakkar; Stuart Winston; Yunren Bolortuya; Radhika Basheer; Robert W McCarley
Journal:  Eur J Neurosci       Date:  2006-10       Impact factor: 3.386

9.  EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.

Authors:  Te Liu; Lengchen Hou; Yongyi Huang
Journal:  Tumour Biol       Date:  2014-04-27

10.  RNAi off-targeting: Light at the end of the tunnel.

Authors:  Kirk Brown; Dmitry Samarsky
Journal:  J RNAi Gene Silencing       Date:  2006-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.